Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2002
10/31/2002CA2444036A1 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002CA2443946A1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002CA2442112A1 Use of creatine for the amelioration of oxidative stress
10/31/2002CA2439960A1 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor antagonists)
10/31/2002CA2439693A1 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002CA2436240A1 Composition, containing carnitine and huperzin for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
10/30/2002EP1252892A1 Composition for reducing mental fatigue, composition for maintaining and enhancing concentration, and composition for maintaining and enhancing mental vigor
10/30/2002EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002EP1252330A2 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
10/30/2002EP1252323A2 Virus strains for the oncolytic treatment of cancer
10/30/2002EP1252322A2 Herpes virus strains for gene therapy
10/30/2002EP1252299A2 Aspartyl proteases
10/30/2002EP1252298A2 Phosphodiesterases
10/30/2002EP1252189A2 Novel human nucleic acid molecules and polypeptides encoding cation channels
10/30/2002EP1252188A2 G-protein coupled receptors
10/30/2002EP1252170A2 Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
10/30/2002EP1252165A1 Isoxazolo pyrimidinones and the use thereof
10/30/2002EP1252163A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
10/30/2002EP1252161A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor
10/30/2002EP1252158A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
10/30/2002EP1252157A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
10/30/2002EP1252156A1 Blockade of voltage dependent sodium channels
10/30/2002EP1252154A1 Heterocyclic amide derivatives
10/30/2002EP1252153A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
10/30/2002EP1252152A1 Urea compounds as inhibitors for vla-4
10/30/2002EP1252150A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
10/30/2002EP1252144A1 Substituted glutarimides and use thereof il-12 production inhibitors
10/30/2002EP1252143A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives
10/30/2002EP1252133A2 Pharmaceutical compounds
10/30/2002EP1251873A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases
10/30/2002EP1251862A1 Ophthalmic compositions for treating ocular hypertension
10/30/2002EP1251860A1 Somnogenic activity of non-pathogenic lactic acid bacteria
10/30/2002EP1251856A1 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices
10/30/2002EP1251855A1 Selective estrogen receptor modulators in combination with estrogens
10/30/2002EP1251854A2 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
10/30/2002EP1251853A1 Transdermal therapeutic system for the administration of zaleplon
10/30/2002EP1251848A1 Gyrase inhibitors and uses thereof
10/30/2002EP1251842A2 Use of modafinil for making a medicine for correcting disorders affecting vigilance related to myopathies
10/30/2002EP1251841A1 Aqueous solution for treating degenerative or autoimmune diseases and as immunomodulatory agent
10/30/2002EP1251840A2 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
10/30/2002EP1251837A2 Compounds and methods for modulating cerebral amyloid angiopathy
10/30/2002EP1251829A1 Electrospun pharmaceutical compositions
10/30/2002EP1140973A4 Protein-protein interactions in neurodegenerative disorders
10/30/2002EP1137416B1 Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture of a medicament for the treatment of glycolipid storage diseases
10/30/2002EP1061925B1 Combination of a gaba-a alpha 5 inverse agonist and a nicotinic agonist
10/30/2002EP0996613B1 Pure cis-tramadol hydrochloride production
10/30/2002CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer
10/30/2002CN1377408A The PRV-1 gene and use thereof
10/30/2002CN1377368A 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
10/30/2002CN1377367A Sapogenin derivatives and their use in the treatment of cognitive dysfunction
10/30/2002CN1377366A 5-hydroxysapogenin derivatives with anti-dementia activity
10/30/2002CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002CN1377355A Amino substituted pyrazolo [1,5-2]-1,5-pyrimidines and pyrazolo [1,5-2]-1,3, 5-triazines
10/30/2002CN1377354A Certain alkylene diamine-substituted pyrazolo [1,5-a]-1,5-pyrimidines and pyrazolo [1,5-a]-1,3,5-triazines
10/30/2002CN1377353A Purine derivatives having phosphodiesterase IN inhibition activity
10/30/2002CN1377352A Selective antagonists of A28 adenosine receptors
10/30/2002CN1377351A Azaindolizinone derivatives and cerebral function improvers containing the same as the active ingredient
10/30/2002CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
10/30/2002CN1377344A Inhibitor of cysteinyl aspartic acid proteinase
10/30/2002CN1377278A Prevention and treatment of amyloidogenic disease
10/30/2002CN1377276A Protein polymerization inhibitors and methods of use
10/30/2002CN1377268A Cell adhesion inhibitors
10/30/2002CN1377267A Retard form containing 2-lipoic acid (derivatives)
10/30/2002CN1377265A Use of agonists of gabab receptors and pharmaceutically acceptable derivates thereof, in the therapy of maintaining nicotine abstinence-dependent patients
10/30/2002CN1377263A Neuropathy improves containing nitrogenous compounds as the active ingredient
10/30/2002CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/30/2002CN1376511A Medicine for preventing and treating neurasthenia
10/30/2002CN1376496A Antagonistic decomposer for nicotine toxin
10/30/2002CN1376475A Medicine for threating rheumatism, rheumatoid disease, lumbar intervertebral disk protrusion, hyperosteogeny and ischias and its preparing process
10/30/2002CN1093423C Novel brain endotheliai cell protein and methods for its use
10/30/2002CN1093422C Kelp product used as tranquilizer and soporific or health tonic and its preparation
10/30/2002CN1093419C Sobering-up tea
10/30/2002CA2383469A1 Treatment of t-cell mediated diseases
10/29/2002US6472436 Blocking amyloid protein toxicity in cells using polycylic compounds. also provided are novel methods of decreasing amyloid protein production in cells and methods of inhibiting cell death. invention methods can be used to prevent and treat
10/29/2002US6472431 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
10/29/2002US6472423 Pharmaceutical composition
10/29/2002US6472422 Treating drug addiction
10/29/2002US6472421 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor
10/29/2002US6472418 Non-peptide NK1 receptors antagonists
10/29/2002US6472413 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
10/29/2002US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002US6472408 Two 5- amino-5,6,7,8-tetrahydroquinoline fragments joined together by a divalent linking group; cholinesterase inhibitors
10/29/2002US6472402 Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives
10/29/2002US6472401 Administering an antiallergen of loratadine or metabolite of loratadine, desloratadine; migraines, stroke, orthostatic hypotension, gastrointestinal stasis, nausea, dizziness and jet lag; also psychological disorders; 5-ht7 receptors
10/29/2002US6472392 Triazole compounds and the use thereof as dopamine-D3 -ligands
10/29/2002US6472390 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
10/29/2002US6472388 Psychotherapeutic agents.
10/29/2002US6472387 Methods of using compounds as neuro-protective agents
10/29/2002US6472378 Compositions and methods for treatment of mitochondrial diseases
10/29/2002US6472368 Compounds and methods for modulating adhesion molecule function
10/29/2002US6472367 Compounds and methods for modulating OB-cadherin mediated cell adhesion
10/29/2002US6472178 Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
10/29/2002US6472172 DNA encoding a novel human inhibitor-of-apoptosis protein
10/29/2002US6472165 Modulatory binding site in potassium channels for screening and finding new active ingredients
10/29/2002US6472158 Ustilipides, method for the production and the use thereof
10/29/2002US6472145 A mobile ionophore composition effective to modulate app catabolism without substantially altering the viability of app-containing cells; inhibits amyloid deposition; alzheimer's disease; nontoxic
10/29/2002US6472140 α-2- macroglobulin therapies and drug screening methods for Alzheimer's disease.
10/29/2002US6471997 Antagonist of calcitonin gene related peptide, cgrp and/or of substance p; cosmetic
1 ... 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 ... 1833